REUNION

Shanghai Ruining Biotechnology Co., Ltd. (referred to as "REUNION") focuses on the research and development of innovative medical devices, providing systematic solutions for clinical applications such as tumor radiotherapy protection, tumor embolization, wound repair, and anti-tumor drug delivery. REUNION is deeply engaged in the research and industrial transformation of medical hydrogels, striving to become an internationally leading hydrogel technology platform. It has established in-depth cooperative relationships with top-tier tertiary hospitals such as Peking Union Medical College Hospital, Fudan University Shanghai Cancer Center, Zhongshan Hospital Affiliated to Fudan University, and Shanghai Sixth People's Hospital. REUNION gathers professional talents from various fields including materials, chemistry, biomedical engineering, and clinical medicine. With the continuous increase in the company's R&D investment, it is constantly achieving new breakthroughs.